their infusion would allie good thrombolytic activity and reduced hemorragic risks , usually related to fibrinogen and others coagulation factors degradation t-pa and scu-pa are natural , physiological substances , obtained by recombinant dna technology . t-pa infusion in acute myocardial infusion ( ami ) has been shown to be at least as efficient than intracoronary streptokinase ( sk ) administration , but fibrinogenolysis was much lower as compared to sk .
C0016006
fibrinogen
C0005789
coagulation factors